| Identification | Back Directory | [Name]
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) | [CAS]
112188-16-6 | [Synonyms]
Gd-DO 3A
Gadobutrol Impurity 100
Gadolinium Butanol Impurity 7
Gadolinium alcohol impurity C
Gadoteridol Related CoMpound B
Des(2-Hydroxypropyl) Gadoteridol
Gadobutrol EP Impurity C (Gadoteridol USP Related Compound B)
gadolinium(III) 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid gadolinium complex
2-[4,7-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate:gadolinium(3+)
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, gadolinium complex (Gadobutrol Impurity)
Gadolinium, [1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-
Gadoteridol Related Compound B (1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium (1287653)
Gadoteridol Related Compound B (50 mg) (1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt)
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) | [Molecular Formula]
C14H22GdN4O6 | [MDL Number]
MFCD28976075 | [MOL File]
112188-16-6.mol | [Molecular Weight]
499.6 |
| Chemical Properties | Back Directory | [Melting point ]
>300°C | [storage temp. ]
Hygroscopic, Refrigerator, under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
White to Off-White | [Stability:]
Hygroscopic | [Major Application]
pharmaceutical (small molecule) | [InChI]
InChI=1S/C14H25N4O6.Gd/c19-12(20)9-16-3-1-15-2-4-17(10-13(21)22)6-8-18(7-5-16)11-14(23)24;/h1-11H2,(H,19,20)(H,21,22)(H,23,24);/q-1;+4/p-3 | [InChIKey]
ADBHHYXJOIUPRL-UHFFFAOYSA-K | [SMILES]
O=C1CN23CCN45CCN6CCN7(CC2)CC(=O)[O-][Gd+3]3476([O-]C(=O)C5)[O-]1 |
| Hazard Information | Back Directory | [Uses]
Des(2-hydroxypropyl) Gadoteridol is a contrast imaging agent metabolite from Gadoteridol (G125900), used as an MRI contrast chelating agent. |
|
|